Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
作者信息
Christie T
出版信息
J Reprod Med. 1983 Jan;28(1 Suppl):63-5.
PMID:6403701
Abstract
摘要
相似文献
1
Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.0.15毫克左炔诺孕酮与0.03毫克炔雌醇比例的研发。
J Reprod Med. 1983 Jan;28(1 Suppl):63-5.
2
Clinical experience with a low-dose contraceptive agent. European studies.低剂量避孕药的临床经验。欧洲研究。
J Reprod Med. 1983 Jan;28(1 Suppl):71-6.
3
A new ultra-low-dose combination oral contraceptive.一种新型超低剂量复方口服避孕药。
J Reprod Med. 1983 Jan;28(1 Suppl):81-4.
4
Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.含0.15毫克左炔诺孕酮和0.03毫克炔雌醇的避孕药。拉丁美洲的临床研究。
J Reprod Med. 1983 Jan;28(1 Suppl):77-80.
5
Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.口服避孕药的进展。左炔诺孕酮和炔雌醇的国际综述。
J Reprod Med. 1983 Jan;28(1 Suppl):53-6.
6
The 150/30 formulation. Experience in the United Kingdom.
J Reprod Med. 1983 Jan;28(1 Suppl):66-70.
7
Oral contraception, 1986. Focus on Triphasil.口服避孕药，1986年。聚焦于三相片。
J Reprod Med. 1986 Jun;31(6 Suppl):559-64.
8
[Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
Akush Ginekol (Sofiia). 1992;31(2):42-3.
9
Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.高比例左炔诺孕酮/炔雌醇作为口服避孕药治疗期间的卵巢功能。
Gynecol Obstet Invest. 1982;14(2):97-105. doi: 10.1159/000299457.
10
[Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
Adv Contracept. 1994 Jul;10 Suppl 1:41-9.
Zotero 插件